interleukin-2 antagonists (Sunesis)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nameinterleukin-2 antagonists (Sunesis)
Drug Alias NameIL-2 antagonists (Sunesis)SP-990SP-4206
ClassificationSmall molecules
Mechanisms of ActionInterleukin-2 receptor antagonists
TargetsInterleukin-2 receptor
Therapy Area/IndicationsGraft vs Host Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesViracta Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesViracta Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsGraft vs Host Disease

Other Information

ATC CodeN/A
Related LinksN/A